查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1858137

急诊无针连接器市场：按材料、最终用户、连接器类型、应用和分销管道划分 - 全球预测 2025-2032

Acute Care Needleless Connectors Market by Material, End User, Connector Type, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，急诊无针连接器市场将成长至 11.9731 亿美元，复合年增长率为 7.59%。

关键市场统计数据
基准年 2024 6.6655亿美元
预计年份：2025年 7.1829亿美元
预测年份 2032 11.9731亿美元
复合年增长率 (%) 7.59%

无针连接器已成为急诊环境中安全血管通路的核心，影响整个医疗保健系统的临床工作流程、感染控制措施和采购决策。这些装置能够实现输液和抽血等治疗的频繁通路，同时降低与针头使用相关的风险。随着临床医生和供应链负责人面临预算日益紧张以及对安全性和可靠性要求不断提高的挑战，了解装置的特性、相容性要求和生命週期考量变得愈发重要。

近年来，设计改进的重点在于防止洩漏、易于消毒以及与标准化连接系统的兼容性。这些工程技术的进步与不断发展的临床通讯协定相契合，旨在减少中心静脉导管相关血流感染并优化输注精确度。因此，相关人员必须权衡临床效能、设备成本、法规遵循以及与现有输注平台的整合性。

本导言透过重点阐述推动无针连接器市场发展的临床需求和采购现实，为后续分析奠定了基础。同时，它也为接下来的详细讨论做好了铺垫，包括市场变化、关税影响、细分市场动态、区域行为和战略应对措施，从而在深入探讨具体研究结果和建议之前，为读者提供清晰的框架。

医疗器材创新、感染控制预期和供应链策略的变革性转变将再形成采购和临床应用优先事项。

在技​​术改进、感染预防日益重视以及供应链重组的推动下，无针连接器领域正经历着一场变革。材料和连接器几何形状的创新提高了相容性并减少了血液回流，而标准化鲁尔介面和快速断开选项的采用则加速了不同输液系统间设备的互通性。同时，风险规避型临床管治也提升了设备属性的重要性，例如易于消毒和故障模式的可视性，促使采购者优先选择那些能够显着降低污染风险的产品。

随着製造商和医疗保健系统应对过去的供应链中断和持续的地缘政治不确定性，供应链韧性已成为焦点。企业正日益多元化筹资策略，并对替代供应商进行资格认证，以降低单一供应商风险。监管也在同步发展，对医疗器材检验、上市后监测和不利事件透明度的要求更加明确。这种监管趋势提升了能够为医疗设备提供可靠临床证据和可追溯性的供应商的价值。

总而言之，这些变化正在改变供应商的选择标准，并加速能够同时满足临床性能阈值和严格采购标准的供应商之间的整合。因此，医疗机构和製造商必须调整其在采购、研发和监管方面的策略，以保持竞争力。

评估美国关税实施至2025年期间的累积营运和采购影响

2025年美国关税调整为经销商带来了复杂的商业环境。这些政策变化改变了进口组件和零件的到岸成本，迫使先前严重依赖跨境采购的製造商重新评估其采购布局。为此，一些製造商转向近岸外包或双重采购策略，以确保利润率并维持可靠的交货时间。

对于经销商和医院采购部门而言，关税的增加增加了他们在不降低安全标准的前提下提供价值的压力。合约谈判越来越反映受关税影响的商品，采购方也要求提高商品资讯的透明度，以便有效地模拟总体拥有成本。这促使临床医生和供应链团队更加紧密地合作，以寻找在保持设备性能的同时，最大限度地降低财务影响的临床等效替代方案。

监管和合规部门也会受到间接影响，因为製造地和供应链的变更需要更新文件，在某些情况下还需要额外的验证工作。因此，那些主动重组製造地地点或投资供应链视觉化工具的组织能够更顺利地应对这些变化，从而维持服务水准并最大限度地减少临床中断。

整合材料选择、终端用户环境、连接器类型、临床应用和通路的全面细分洞察

细分市场分析揭示了影响无针连接器产品选择、购买行为和临床应用的多个维度。材料选择大致可分为金属和塑胶两大类，其中金属材料主要为铝和不銹钢，兼具耐用性和热稳定性；塑胶材料主要为聚碳酸酯和聚丙烯，兼顾强度、成本效益以及与一次性使用通讯协定的兼容性。这些材料差异会影响灭菌途径、器械寿命以及临床应用的可靠性认知。

终端使用者细分市场进一步明确了门诊手术中心、家庭医疗保健和医院环境的需求模式。门诊手术中心包括医生诊所和门诊诊断中心，这些场所的采购逻辑通常以吞吐量和一次性使用为主导。同时，家庭医疗保健环境又细分为家庭透析治疗和居家输液治疗，这两种情况都需要针对患者操作、易用性和更长的使用寿命进行最佳化的设备。医院包括二级和三级医疗机构，这些机构优先考虑感染控制效果、与复杂输液方案的整合以及与不同设备库存的兼容性。

连接器类型是关键的功能区别，包括鲁尔锁式、鲁尔滑式和快速断开式三种选择。鲁尔锁式和鲁尔滑式又细分为母头和公头两种配置，分别影响与注射器、导管和延长管的兼容性。快速断开式设计则有单件式和两件式两种，强调快速连接和可靠密封，适用于频繁操作的场景。血液采样进一步区分动脉采样和静脉采样；药物输送区分镇痛药、抗生素和化疗；输液治疗区分Bolus和持续输注，二者对性能的要求各不相同。

分销通路细分透过辨识直销通路、经销商通路和线上通路，提供整体情况。经销商包括服务于机构买家的医疗批发商和第三方分销商，而线上管道则包括能够快速补货和处理小批量订单的电商平台和製造商网站。每个通路对前置作业时间、服务水准和单据的要求各不相同，这反过来又会影响最终用户群体的产品销售和库存方式。

影响美洲、欧洲、中东和非洲以及亚太地区需求模式的关键区域行为和采购动态

区域动态正在影响美洲、欧洲、中东和非洲以及亚太地区的产品偏好、监管重点和供应商策略。在美洲，大型一体化分销网络和集中采购模式往往强调成本效益、与现有输液平台的互通性以及供应商在当地提供稳定配送的能力。该地区更青睐那些兼具临床证据和可扩展物流解决方案的产品。

欧洲、中东和非洲的监管和采购环境各不相同，各国的报销政策、临床通讯协定的差异以及供应链成熟度的差异都会影响产品的采用率。欧洲市场通常更注重严格的合格评定和临床文件，而中东和非洲市场则可能更重视产品的可近性和对当地临床实践的适应性。这些差异要求供应商针对每个国家和地区调整其监管申报和商业性策略。

亚太地区呈现出独特的市场动态，其医疗基础设施快速扩张，居家医疗服务显着成长，製造业实力雄厚。该地区部分市场倾向于选择本地生产、价格具竞争力的产品，而有些市场则需要配备先进功能的高端设备，以满足三级医院的需求。在所有地区，与当地监管机构保持沟通以及与当地经销商伙伴关係，对于成功进入市场并实现持续市场认可仍然至关重要。

策略竞争情报揭示领先製造商、专业创新者和供应合作伙伴如何透过设计、证据和服务实现差异化。

无针连接器领域主要企业的竞争格局反映了创新、规模和服务能力之间的平衡。市场领导者利用其丰富的产品系列、成熟的分销网络和深厚的临床证据，为大型机构客户和多家医院系统提供支援。这些公司致力于产品迭代改进、以用户为中心的设计以及临床研究，以证明其产品能够降低污染并改善操作性能。

中型製造商和专业创新者透过专注于技术优势来脱颖而出，例如独特的密封机制、更佳的清洁性能以及可缩短连接时间的创新快速断开设计。契约製造製造商和垂直整合供应商透过提供灵活的生产能力和联合开发伙伴关係，加速差异化产品的上市，从而发挥战略作用。同时，灵活的新兴企业和医疗设备创新者专注于细分应用领域，瞄准家庭医疗保健和门诊病人市场，提供量身定制的解决方案，以方便患者使用并降低生命週期成本。

成功的竞争对手强调合规性、透明的上市后监管以及与医院采购週期相符的服务水准承诺。与经销商和临床专家伙伴关係能够推动产品应用，而对订单管理和可追溯性数位化工具的投资则有助于供应商在竞争激烈的采购环境中脱颖而出。

为製造商和医疗保健系统提供切实可行的策略建议，以增强产品采纳率、供应链韧性和监管协调性。

产业领导者应优先采取一系列策略行动，以应对临床需求、关税带来的成本压力以及不断变化的采购预期。首先，投资于产品设计改进，以显着降低污染风险并改善使用者人体工学，同时辅以强有力的临床检验，从而建立买家信心。其次，透过利用近岸外包、双重采购和合格的委託製造製造商等手段，实现生产和采购布局多元化，以减轻关税和供应中断的影响，从而维持业务连续性。

第三，我们将加强监管和上市后监测能力，简化跨辖区核准，并向机构投资者提供透明的安全资料。第四，我们将发展灵活的商业模式，包括直接合约、经销商合作和数位化销售管道，以满足不同规模的订单和采购偏好。第五，我们将透过提供培训、技术服务和数据主导的库存管理，提升售后服务，降低临床风险，并优化存量基准。

协同执行这些措施能够帮助企业保障净利率、加速临床应用并实现差异化。与临床终端使用者和采购团队的合作，可确保产品蓝图和商业策略与当地需求和机构限制相符。

一种透明且可重复的调查方法，结合了初步临床访谈、二次药物分析和三角验证资料整合。

本分析的调查方法结合了定性和定量方法，以确保其严谨性和有效性。主要研究包括对临床负责人、采购人员、供应商和监管专家进行结构化访谈，以获取关于设备性能、采购驱动因素和营运限制的第一手观点。来自临床现场的观察回馈补充了相关人员的访谈，以检验关于设备操作、相容性和对现场工作流程影响的假设。

二级研究利用官方监管文件、产品说明书、专利文件和同行评审的临床研究，全面了解了设备设计、材料科学和安全性能。竞争分析则利用产品目录、分销协议和第三方报告，描绘了市场策略和通路结构。资料整合采用跨来源三角验证法，以调和临床偏好和采购行为洞察之间的差异，并得出平衡的结论。

分析方法包括对访谈记录进行定性编码、对临床需求进行主题分析以及建立供应链应急情境图。在整个调查方法中，我们强调分析程序的透明度和可重复性，并透过同侪审查检验，以确保研究结果对临床、商业和供应链相关人员具有实际应用价值。

对临床优先事项、供应弹性以及监管协调进行综合分析，将决定未来的应用和病人安全结果。

在急诊环境中，无针连接器在临床安全、器械工程和供应链管理方面占据着至关重要的地位。现有证据表明，人们对能够提供显着感染控制效益、与输液平台无缝相容以及可预测的供应连续性的器械期望日益增长。这些期望正在推动不同终端用户群体和地理区域的需求差异，为那些能够透过临床检验证明产品性能并透过稳健的供应模式展现产品可用性的製造商创造了机会。

关税主导的成本动态变化与日益严格的监管审查相结合，使得营运透明度和适应性筹资策略变得愈发重要。能够将产品开发、法规遵循和商业性执行有机结合的组织，其绩效将优于那些孤立处理各个环节的组织。因此，相关人员应将医疗设备的选择和采购视为一个需要临床、供应链和监管团队通力合作的整合过程。

最终，製造商和医疗服务提供者现在做出的战略选择将影响未来数年的产品应用模式和病人安全结果。优先考虑具有临床意义的创新、供应链韧性和清晰的监管路径，是获得永续竞争优势和改善医疗服务的最直接途径。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 为了最大限度地减少 ICU 环境中的污染，采用防腐屏障技术的封闭式鲁尔锁连接器正被越来越多地采用。
  • 重症加护中对压力中性闭式迴路输液装置的需求不断增长，以预防空气栓塞。
  • 开发一种具有疏水性薄膜过滤器的整合式过滤过滤连接器，以降低急诊环境中的感染率。
  • 转向单手操作、低阻力无针连接器设计，以优化急诊工作流程效率
  • 无针连接器与电子输液帮浦和智慧医院系统的兼容性对于提高安全性将变得越来越重要。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按材料分類的急诊无针连接器市场

  • 金属
    • 铝
    • 不銹钢
  • 塑胶
    • 聚碳酸酯
    • 聚丙烯

9. 按最终用户分類的急诊无针连接器市场

  • 门诊手术中心
    • 诊所
    • 门诊诊断中心
  • 家庭医疗保健
    • 家庭透析治疗
    • 家庭输液治疗
  • 医院
    • 二级护理
    • 三级医疗

10. 按连接器类型分類的急诊无针连接器市场

  • 诱饵锁
    • 女士
    • 男性
  • 诱饵滑
    • 女士
    • 男性
  • 快速断开
    • 一件
    • 两件套

第十一章 按应用分類的急诊无针连接器市场

  • 血液样本采集
    • 动脉采样
    • 静脉取样
  • 药物递送
    • 止痛药
    • 抗生素
    • 化疗
  • 点滴疗法
    • Bolus输液
    • 常规输液

第十二章 按分销管道分類的急诊无针连接器市场

  • 直销
  • 经销商
    • 医疗批发商
    • 第三方经销商
  • 线上管道
    • 电子商务平台
    • 製造商网站

13. 各地区急诊无针连接器市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 急诊无针连接器市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各国急诊无针连接器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Becton, Dickinson and Company
    • ICU Medical, Inc.
    • Smiths Medical, Inc.
    • B. Braun Melsungen AG
    • Teleflex Incorporated
    • Terumo Corporation
    • Nipro Corporation
    • Baxter International Inc.
    • Merit Medical Systems, Inc.
    • Vygon SA
Product Code: MRR-C002B1C99769

The Acute Care Needleless Connectors Market is projected to grow by USD 1,197.31 million at a CAGR of 7.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 666.55 million
Estimated Year [2025] USD 718.29 million
Forecast Year [2032] USD 1,197.31 million
CAGR (%) 7.59%

Needleless connectors have become central to safe vascular access in acute care environments, shaping clinical workflows, infection control practices, and procurement decisions across healthcare systems. These devices reduce the risks associated with needle use while enabling frequent access for therapies such as infusion and blood sampling. As clinicians and supply chain leaders navigate tighter budgets and higher expectations for safety and reliability, understanding device features, compatibility requirements, and lifecycle considerations has grown more important.

Over recent years, design refinements have prioritized leak prevention, ease of disinfection, and compatibility with standardized connection systems. These engineering advances intersect with evolving clinical protocols aimed at reducing central line-associated bloodstream infections and optimizing infusion accuracy. Consequently, stakeholders must balance clinical performance against device cost, regulatory compliance, and integration with existing infusion platforms.

This introduction frames the subsequent analysis by establishing the clinical imperatives and procurement realities that drive interest in needleless connectors. It sets the stage for deeper examination of market shifts, tariff impacts, segmentation dynamics, regional behaviors, and strategic responses that follow, providing readers with a clear orientation before moving into detailed findings and recommendations.

Transformative shifts in device innovation, infection control expectations, and supply chain strategies reshaping procurement and clinical adoption priorities

The landscape for needleless connectors is undergoing transformative shifts driven by technological refinement, heightened infection-prevention priorities, and supply chain recalibration. Innovations in materials and connector geometries have improved compatibility and reduced blood reflux, while adoption of standardized luer interfaces and quick-disconnect options has accelerated device interoperability across infusion systems. At the same time, risk-averse clinical governance has elevated device attributes such as ease of decontamination and failure-mode visibility, prompting purchasers to prioritize products that demonstrably reduce contamination risks.

Supply chain resilience has moved to the forefront as manufacturers and health systems respond to past disruptions and ongoing geopolitical uncertainties. Firms are increasingly diversifying sourcing strategies and qualifying alternate suppliers to mitigate single-source exposure. Regulatory scrutiny has evolved in parallel, with clearer expectations for device validation, post-market surveillance, and adverse-event transparency. This regulatory momentum elevates the value of vendors who can supply robust clinical evidence and traceability for their devices.

Taken together, these shifts change vendor selection criteria and accelerate consolidation among suppliers that can meet both clinical performance thresholds and rigorous procurement standards. As a result, healthcare organizations and manufacturers must adapt strategies across procurement, R&D, and regulatory engagement to sustain competitive positioning.

Assessment of the cumulative operational and procurement effects stemming from United States tariff measures implemented during 2025

Tariff adjustments implemented in the United States in 2025 have created a complex operating environment for manufacturers, distributors, and institutional buyers of needleless connectors. These policy changes have altered landed costs for imported assemblies and components, prompting manufacturers that previously relied heavily on cross-border sourcing to reassess their procurement footprints. In response, some producers have shifted toward nearshoring and dual-sourcing strategies to shield margins and maintain delivery reliability, while others have renegotiated supplier agreements or absorbed short-term cost increases to preserve customer relationships.

For distributors and hospital purchasing departments, the tariffs have compounded pressures to deliver value without compromising safety standards. Contract negotiations increasingly reflect tariff-exposed line items, and buyers now require greater line-item transparency to model total cost of ownership effectively. Clinicians and supply chain teams have therefore collaborated more closely to identify clinically equivalent alternatives that minimize financial impact while preserving device performance.

Regulatory and compliance functions have also felt secondary effects, as changes in manufacturing locations and supply chains necessitate updated documentation and, in some cases, additional validation activities. Consequently, organizations that proactively restructured manufacturing footprints or invested in supply chain visibility tools have navigated these changes more smoothly, preserving service levels and minimizing clinical disruption.

Comprehensive segmentation-driven insights integrating material choices, end-user environments, connector types, clinical applications, and distribution pathways

Segmentation analysis reveals multiple axes that determine product selection, purchasing behavior, and clinical deployment for needleless connectors. Material choices split broadly between metal and plastic construction, with metal variants covering aluminum and stainless steel options that offer durability and thermal stability, while plastic alternatives emphasize polycarbonate and polypropylene formulations that balance strength with cost-efficiency and compatibility with single-use protocols. This material differentiation influences sterilization pathways, device longevity, and perceived clinical robustness.

End-user segmentation further clarifies demand patterns across ambulatory surgical centers, home healthcare, and hospital environments. Ambulatory surgical centers encompass clinics and outpatient diagnostic centers where throughput and disposability often dominate purchasing logic, whereas home healthcare settings break down into home dialysis and home infusion therapy contexts that require devices optimized for patient handling, ease of use, and extended shelf-life. Hospitals include secondary and tertiary care facilities that prioritize infection control outcomes, integration with complex infusion regimens, and compatibility across diverse device inventories.

Connector type represents a crucial functional segmentation, covering luer lock, luer slip, and quick disconnect options. Luer lock and luer slip categories are each subdivided into female and male configurations that affect compatibility with syringes, catheters, and extension sets, while quick disconnect designs appear as one-piece or two-piece solutions that emphasize rapid connection and reliable sealing for high-frequency access scenarios. Application-based segmentation differentiates use cases such as blood sampling, drug delivery, and infusion therapy; blood sampling further distinguishes arterial from venous sampling, drug delivery separates analgesics, antibiotics, and chemotherapy therapies, and infusion therapy splits into bolus infusion and continuous infusion modalities that carry distinct performance requirements.

Distribution channel segmentation rounds out the picture by identifying direct sales, distributors, and online channels. Distributors comprise medical wholesalers and third-party distributors that serve institutional purchasers, while online channels include e-commerce platforms and manufacturer websites that facilitate faster replenishment and smaller order sizes. Each distribution pathway imposes different expectations for lead times, service levels, and documentation, thereby affecting how products are marketed and stocked across end-user segments.

Key regional behaviors and procurement dynamics shaping demand patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories

Regional dynamics shape product preferences, regulatory priorities, and supplier strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific geographies. In the Americas, large integrated delivery networks and centralized procurement models tend to emphasize cost effectiveness, interoperability with existing infusion platforms, and suppliers' ability to provide consistent national distribution. This region shows a preference for products that combine clinical evidence with scalable logistics solutions.

Europe, Middle East & Africa displays a heterogeneous regulatory and procurement landscape where national reimbursement policies, varying clinical protocols, and diverse supply chain maturities influence adoption rates. European markets often emphasize stringent conformity assessment and clinical documentation, while markets in the Middle East and Africa may prioritize availability and adaptability to local clinical practices. These differences require suppliers to tailor regulatory dossiers and commercial approaches by country or subregion.

Asia-Pacific presents distinct dynamics driven by rapid healthcare infrastructure expansion, significant growth in home healthcare services, and a wide range of manufacturing capabilities. Some markets in this region favor locally produced, cost-competitive products, while others seek premium devices with advanced features for tertiary hospitals. Across all regions, local regulatory engagement and partnerships with regional distributors remain critical to successful market entry and sustained adoption.

Strategic competitive intelligence revealing how leading manufacturers, specialized innovators, and supply partners drive differentiation through design, evidence, and service

Competitive behavior among leading companies in the needleless connector space reflects a balance of innovation, scale, and service capability. Market leaders leverage broad product portfolios, established distribution networks, and deep clinical evidence packages to support large institutional customers and multi-hospital systems. These firms invest in iterative product enhancements, user-centric design, and clinical studies that demonstrate reductions in contamination and improved handling characteristics.

Mid-tier manufacturers and specialist innovators differentiate through focused technical advantages, such as proprietary sealing mechanisms, improved flushability, or novel quick-disconnect designs that reduce connection time. Contract manufacturers and vertically integrated suppliers play a strategic role by offering flexible production capacity and co-development partnerships, enabling faster time-to-market for differentiated offerings. Meanwhile, agile start-ups and medical device innovators concentrate on niche applications, targeting home healthcare and outpatient segments with solutions tailored to patient usability and reduced lifecycle costs.

Across the competitive spectrum, successful companies emphasize regulatory readiness, transparent post-market surveillance, and service-level commitments that align with hospital procurement cycles. Partnerships with distributors and clinical champions frequently accelerate adoption, while investment in digital tools for order management and traceability differentiates vendors in tight procurement environments.

Actionable strategic recommendations for manufacturers and health systems to strengthen product adoption, supply resilience, and regulatory alignment

Industry leaders should prioritize a set of strategic actions to respond to clinical demands, tariff-induced cost pressures, and evolving procurement expectations. First, invest in product design improvements that demonstrate measurable reductions in contamination risk and improved user ergonomics, and pair those enhancements with robust clinical validation to build purchaser confidence. Second, diversify manufacturing and sourcing footprints to mitigate tariff exposure and supply interruptions, using nearshoring, dual sourcing, and qualified contract manufacturers as levers to maintain continuity.

Third, strengthen regulatory and post-market surveillance capabilities to streamline approvals across jurisdictions and to provide transparent safety data to institutional buyers. Fourth, develop flexible commercial models including direct contracts, distributor partnerships, and digital sales channels that accommodate varying order sizes and procurement preferences. Fifth, enhance after-sales support by offering training, technical service, and data-driven inventory management to reduce clinical risk and optimize stock levels at point of care.

By executing these measures in concert, companies can protect margins, accelerate clinical adoption, and create defensible differentiation. Collaboration with clinical end users and procurement teams will ensure that product roadmaps and commercial strategies remain aligned with frontline needs and institutional constraints.

Transparent and reproducible research methodology combining primary clinical interviews, secondary regulatory analysis, and triangulated data synthesis

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure rigor and relevance. Primary research included structured interviews with clinical leaders, procurement directors, suppliers, and regulatory specialists to capture firsthand perspectives on device performance, purchasing drivers, and operational constraints. Observational inputs from clinical settings complemented stakeholder interviews to validate assumptions about device handling, compatibility, and frontline workflow impact.

Secondary research leveraged public regulatory filings, product instructions for use, patent literature, and peer-reviewed clinical studies to build a comprehensive view of device design, materials science, and safety performance. Competitive profiling relied on product catalogs, distribution agreements, and third-party reporting to map go-to-market strategies and channel structures. Data synthesis involved triangulation across sources, reconciling differences between clinical preference insights and procurement behavior to produce balanced conclusions.

Analytical methods incorporated qualitative coding of interview transcripts, thematic analysis of clinical requirements, and scenario mapping for supply chain contingencies. Throughout the methodology, emphasis was placed on transparency, reproducibility of analytical steps, and validation through expert review to ensure the findings are actionable for clinical, commercial, and supply chain stakeholders.

Concluding synthesis of clinical priorities, supply resilience, and regulatory alignment that will determine future adoption and patient safety outcomes

Needleless connectors occupy a vital intersection of clinical safety, device engineering, and supply chain management within acute care environments. The collective evidence points to rising expectations for devices that deliver demonstrable infection control benefits, seamless compatibility across infusion platforms, and predictable supply continuity. These expectations drive differentiated demand across end-user segments and regions and create opportunities for manufacturers able to prove performance through clinical validation and deliverability through resilient supply models.

The intersection of tariff-driven cost dynamics and heightened regulatory scrutiny increases the premium on operational transparency and adaptive sourcing strategies. Organizations that align product development, regulatory readiness, and commercial execution will outperform those that treat these elements in isolation. Consequently, stakeholders should view device selection and procurement as an integrated process requiring collaboration among clinical, supply chain, and regulatory teams.

In closing, the strategic choices made by manufacturers and healthcare providers today will shape adoption patterns and patient safety outcomes over the coming years. Prioritizing clinically meaningful innovation, supply chain resilience, and clear regulatory pathways offers the most direct route to sustainable competitive advantage and improved care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of closed male luer lock connectors with antiseptic barrier technology to minimize contamination in ICU settings
  • 5.2. Increasing demand for closed system transfer devices with pressure-neutral designs to prevent air embolism in critical care
  • 5.3. Development of integrated filtration needleless connectors with hydrophobic membrane filters to lower infection rates in acute care
  • 5.4. Shift towards low-resistance one-handed operable needleless connector designs to optimize workflow efficiency in emergency departments
  • 5.5. Growing emphasis on compatibility of needleless connectors with electronic infusion pumps and smart hospital systems for improved safety

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute Care Needleless Connectors Market, by Material

  • 8.1. Metal
    • 8.1.1. Aluminum
    • 8.1.2. Stainless Steel
  • 8.2. Plastic
    • 8.2.1. Polycarbonate
    • 8.2.2. Polypropylene

9. Acute Care Needleless Connectors Market, by End User

  • 9.1. Ambulatory Surgical Center
    • 9.1.1. Clinics
    • 9.1.2. Outpatient Diagnostic Center
  • 9.2. Home Healthcare
    • 9.2.1. Home Dialysis
    • 9.2.2. Home Infusion Therapy
  • 9.3. Hospital
    • 9.3.1. Secondary Care
    • 9.3.2. Tertiary Care

10. Acute Care Needleless Connectors Market, by Connector Type

  • 10.1. Luer Lock
    • 10.1.1. Female
    • 10.1.2. Male
  • 10.2. Luer Slip
    • 10.2.1. Female
    • 10.2.2. Male
  • 10.3. Quick Disconnect
    • 10.3.1. One-Piece
    • 10.3.2. Two-Piece

11. Acute Care Needleless Connectors Market, by Application

  • 11.1. Blood Sampling
    • 11.1.1. Arterial Sampling
    • 11.1.2. Venous Sampling
  • 11.2. Drug Delivery
    • 11.2.1. Analgesics
    • 11.2.2. Antibiotics
    • 11.2.3. Chemotherapy
  • 11.3. Infusion Therapy
    • 11.3.1. Bolus Infusion
    • 11.3.2. Continuous Infusion

12. Acute Care Needleless Connectors Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
    • 12.2.1. Medical Wholesalers
    • 12.2.2. Third-Party Distributors
  • 12.3. Online Channels
    • 12.3.1. E-Commerce Platforms
    • 12.3.2. Manufacturer Websites

13. Acute Care Needleless Connectors Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Acute Care Needleless Connectors Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Acute Care Needleless Connectors Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Becton, Dickinson and Company
    • 16.3.2. ICU Medical, Inc.
    • 16.3.3. Smiths Medical, Inc.
    • 16.3.4. B. Braun Melsungen AG
    • 16.3.5. Teleflex Incorporated
    • 16.3.6. Terumo Corporation
    • 16.3.7. Nipro Corporation
    • 16.3.8. Baxter International Inc.
    • 16.3.9. Merit Medical Systems, Inc.
    • 16.3.10. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ACUTE CARE NEEDLELESS CONNECTORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ACUTE CARE NEEDLELESS CONNECTORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ACUTE CARE NEEDLELESS CONNECTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY OUTPATIENT DIAGNOSTIC CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOME INFUSION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONNECTOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER LOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY LUER SLIP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY QUICK DISCONNECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONE-PIECE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY TWO-PIECE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ARTERIAL SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANALGESICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY BOLUS INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MEDICAL WHOLESALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ACUTE CARE NEEDLELESS CONNECTORS MARK